| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
ADME of Biologics—What Have We Learned from Small Molecules?
|
Prueksaritanont, Thomayant
|
|
2012
|
14 |
3 |
p. 410-419
|
article
|
| 2 |
A Platform for Characterizing Therapeutic Monoclonal Antibody Breakdown Products by 2D Chromatography and Top-Down Mass Spectrometry
|
Mazur, Matthew T.
|
|
2012
|
14 |
3 |
p. 530-541
|
article
|
| 3 |
A Technique to Estimate In Vivo Dissolution Profiles Without Data from a Solution
|
Cook, Jack A.
|
|
2012
|
14 |
3 |
p. 433-436
|
article
|
| 4 |
Biopharmaceutic Planning in Pediatric Drug Development
|
Purohit, Vivek S.
|
|
2012
|
14 |
3 |
p. 519-522
|
article
|
| 5 |
Challenges and Opportunities in Achieving Bioequivalence for Fixed-Dose Combination Products
|
Mitra, Amitava
|
|
2012
|
14 |
3 |
p. 646-655
|
article
|
| 6 |
Compartmental Tissue Distribution of Antibody Therapeutics: Experimental Approaches and Interpretations
|
Boswell, C. Andrew
|
|
2012
|
14 |
3 |
p. 612-618
|
article
|
| 7 |
Development and Advanced Validation of an Optimized Method for the Quantitation of Aβ42 in Human Cerebrospinal Fluid
|
Cullen, Valerie C.
|
|
2012
|
14 |
3 |
p. 510-518
|
article
|
| 8 |
Effects of Device and Formulation on In Vitro Performance of Dry Powder Inhalers
|
Adams, Wallace P.
|
|
2012
|
14 |
3 |
p. 400-409
|
article
|
| 9 |
Effects of Molecular Weight and Loading on Matrix Metalloproteinase-2 Mediated Release from Poly(Ethylene Glycol) Diacrylate Hydrogels
|
Ross, Amy E.
|
|
2012
|
14 |
3 |
p. 482-490
|
article
|
| 10 |
Fish Drug Analysis—Phish-Pharm: 2011 Update
|
Reimschuessel, Renate
|
|
2012
|
14 |
3 |
p. 481
|
article
|
| 11 |
Glucocorticoid Receptor-Mediated Transcriptional Regulation of N-acetyltransferase 1 Gene Through Distal Promoter
|
Bonamassa, Barbara
|
|
2012
|
14 |
3 |
p. 581-590
|
article
|
| 12 |
In vitro–In Vivo Correlations: Tricks and Traps
|
Cardot, J.-M.
|
|
2012
|
14 |
3 |
p. 491-499
|
article
|
| 13 |
Ligand Binding Assays in the 21st Century Laboratory—A Call for Change
|
Ray, Chad A.
|
|
2012
|
14 |
3 |
p. 377-379
|
article
|
| 14 |
Mechanistic Determinants of Biotherapeutics Absorption Following SC Administration
|
Richter, Wolfgang F.
|
|
2012
|
14 |
3 |
p. 559-570
|
article
|
| 15 |
Nonclinical Dose Formulation: Out of Specification Investigations
|
Appleton, Troy
|
|
2012
|
14 |
3 |
p. 523-529
|
article
|
| 16 |
Pain Assessment in Human Fetus and Infants
|
Bellieni, Carlo Valerio
|
|
2012
|
14 |
3 |
p. 456-461
|
article
|
| 17 |
Paradigm Shift in Toxicity Testing and Modeling
|
Sun, Hongmao
|
|
2012
|
14 |
3 |
p. 473-480
|
article
|
| 18 |
Performance Comparison of Various Maximum Likelihood Nonlinear Mixed-Effects Estimation Methods for Dose–Response Models
|
Plan, Elodie L.
|
|
2012
|
14 |
3 |
p. 420-432
|
article
|
| 19 |
Performance of Methods for Handling Missing Categorical Covariate Data in Population Pharmacokinetic Analyses
|
Keizer, Ron J.
|
|
2012
|
14 |
3 |
p. 601-611
|
article
|
| 20 |
Pharmacokinetic mAb–mAb Interaction: Anti-VEGF mAb Decreases the Distribution of Anti-CEA mAb into Colorectal Tumor Xenografts
|
Abuqayyas, Lubna
|
|
2012
|
14 |
3 |
p. 445-455
|
article
|
| 21 |
Physicochemical Characterization of Complex Drug Substances: Evaluation of Structural Similarities and Differences of Protamine Sulfate from Various Sources
|
Awotwe-Otoo, David
|
|
2012
|
14 |
3 |
p. 619-626
|
article
|
| 22 |
Physiochemical and Biochemical Factors Influencing the Pharmacokinetics of Antibody Therapeutics
|
Bumbaca, Daniela
|
|
2012
|
14 |
3 |
p. 554-558
|
article
|
| 23 |
Physiologically Based Pharmacokinetic Modeling to Investigate Regional Brain Distribution Kinetics in Rats
|
Westerhout, Joost
|
|
2012
|
14 |
3 |
p. 543-553
|
article
|
| 24 |
Population Pharmacokinetics and Pharmacodynamics of Ribavirin in Patients with Chronic Hepatitis C Genotype 1 Infection
|
Jin, Runyan
|
|
2012
|
14 |
3 |
p. 571-580
|
article
|
| 25 |
Predicting the Effects of Anti-angiogenic Agents Targeting Specific VEGF Isoforms
|
Finley, Stacey D.
|
|
2012
|
14 |
3 |
p. 500-509
|
article
|
| 26 |
Re-introduction of a Novel Approach to the Use of Stable Isotopes in Pharmacokinetic Studies
|
Parr, Alan
|
|
2012
|
14 |
3 |
p. 639-645
|
article
|
| 27 |
Retraction note to: Recent advances for the treatment of cocaine abuse: central nervous system immunopharmacotherapy
|
Dickerson, Tobin J.
|
|
2012
|
14 |
3 |
p. 542
|
article
|
| 28 |
Stability of Amorphous Pharmaceutical Solids: Crystal Growth Mechanisms and Effect of Polymer Additives
|
Sun, Ye
|
|
2012
|
14 |
3 |
p. 380-388
|
article
|
| 29 |
Summary Workshop Report: Facilitating Oral Product Development and Reducing Regulatory Burden Through Novel Approaches to Assess Bioavailability/Bioequivalence
|
Polli, James E.
|
|
2012
|
14 |
3 |
p. 627-638
|
article
|
| 30 |
The Use of Modeling Tools to Drive Efficient Oral Product Design
|
Mathias, Neil R.
|
|
2012
|
14 |
3 |
p. 591-600
|
article
|
| 31 |
Tissue Distribution Studies of Protein Therapeutics Using Molecular Probes: Molecular Imaging
|
Williams, Simon-Peter
|
|
2012
|
14 |
3 |
p. 389-399
|
article
|
| 32 |
Toward Global Standards for Comparator Pharmaceutical Products: Case Studies of Amoxicillin, Metronidazole, and Zidovudine in the Americas
|
Löbenberg, Raimar
|
|
2012
|
14 |
3 |
p. 462-472
|
article
|
| 33 |
What about Pain in Disorders of Consciousness?
|
Schnakers, C.
|
|
2012
|
14 |
3 |
p. 437-444
|
article
|
Journal description